About Rapid Novor
Rapid Novor helps biotech and pharmaceutical companies extract the full potential of antibodies in ways never before possible. We provide services and develop new technology that enables timely and reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and developed the first recombinant polyclonal antibody diagnostics. Our technology has empowered thousands of researchers and has the potential to unlock a new universe of discoveries that will shape future research, and benefit global health. At Rapid Novor, we believe that the journey to a world of more effective treatments that cost less and are easier to develop starts with decoding immunity.
Sequence, understand and reproduce antibodies at scale.
Proprietary techniques and bioinformatics deliver unparalleled accuracy, throughput and speed.
Tackle reproducibility issues, secure supply, and accelerate development
- REmAb Monoclonal Antibody
- Protein Sequencing
- REpAb Polyclonal Antibody Protein Sequencing
- de novo Protein Sequencing
- Antibody sequence validation
- HDX-MS Epitope Mapping
- custom services
- Therapeutic Antibody Drug Discovery
- Antibody Engineering
- in vitro Diagnostic Development
- Biosimilar Development
- Antibody Sequencing
- Antibody Characterization